Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.

Zhu X, Castellani RJ, Moreira PI, Aliev G, Shenk JC, Siedlak SL, Harris PLR, Fujioka H, Sayre LM, Szweda PA, Szweda LI, Smith MA, Perry G.

Free Radic Biol Med. 2012 Feb 1;52(3):699-704. doi: 10.1016/j.freeradbiomed.2011.11.004. Epub 2011 Nov 12.

2.

The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.

Shenk JC, Liu J, Fischbach K, Xu K, Puchowicz M, Obrenovich ME, Gasimov E, Alvarez LM, Ames BN, Lamanna JC, Aliev G.

J Neurol Sci. 2009 Aug 15;283(1-2):199-206. doi: 10.1016/j.jns.2009.03.002. Epub 2009 Apr 1.

3.

Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.

Obrenovich ME, Morales LA, Cobb CJ, Shenk JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G, Aliev G.

J Cell Mol Med. 2009 May;13(5):853-65. doi: 10.1111/j.1582-4934.2008.00512.x. Epub 2008 Oct 6. Review.

4.

Antioxidant therapy in Alzheimer's disease: theory and practice.

Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA, Perry G.

Mini Rev Med Chem. 2008 Nov;8(13):1395-406. Review.

5.

Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease.

Aliev G, Gasimov E, Obrenovich ME, Fischbach K, Shenk JC, Smith MA, Perry G.

Vasc Health Risk Manag. 2008;4(3):721-30.

6.

Stem cell niches as clinical targets: the future of anti-ischemic therapy?

Aliev G, Shenk JC, Fischbach K, Perry G.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):590-1. doi: 10.1038/ncpcardio1295. Epub 2008 Jul 15.

PMID:
18628773
7.

Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.

Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, Obrenovich ME, Ward WF, Richardson AG, Smith MA, Gasimov E, Perry G, Ames BN.

J Cell Mol Med. 2009 Feb;13(2):320-33. doi: 10.1111/j.1582-4934.2008.00324.x. Epub 2008 Mar 28.

8.

Alzheimer disease and the role of free radicals in the pathogenesis of the disease.

Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G.

CNS Neurol Disord Drug Targets. 2008 Feb;7(1):3-10. Review.

PMID:
18289026
9.

Nucleic acid oxidation in Alzheimer disease.

Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G.

Free Radic Biol Med. 2008 Apr 15;44(8):1493-505. doi: 10.1016/j.freeradbiomed.2008.01.002. Epub 2008 Jan 18. Review.

PMID:
18258207
10.

Ultrastructural analysis of a murine model of congenital hydrocephalus produced by overexpression of transforming growth factor-beta1 in the central nervous system.

Aliev G, Miller JP, Leifer DW, Obrenovich ME, Shenk JC, Smith MA, Lamanna JC, Perry G, Lust DW, Cohen AR.

J Submicrosc Cytol Pathol. 2006 Jun-Sep;38(2-3):85-91.

PMID:
17784635
11.

Geology of the Central Portion of the Queen Maud Range, Transantarctic Mountains.

Wade FA, Yeats VL, Everett JR, Greenlee DW, Laprade KE, Shenk JC.

Science. 1965 Dec 31;150(3705):1808-9.

PMID:
17841973

Supplemental Content

Loading ...
Support Center